Table 1.
Target peptide (nM)a | Target peptide 1 | Target peptide 2 | Target peptide 3 | Target peptide 4 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
+ MHCII +Alexa488-FRR-HA306-318 | + MHCII +Alexa488-FRR-HA306-318 | + MHCII +Alexa488-FRR-HA306-318 | + MHCII +Alexa488-FRR-HA306-318 | ||||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
20000 | A | ||||||||||||
4000 | B | ||||||||||||
800 | C | ||||||||||||
160 | D | ||||||||||||
32 | E | ||||||||||||
6.4 | F | ||||||||||||
1.28 | G | ||||||||||||
0 | H | FP_no_compb | FP_freec |
Target peptide concentrations starts at 20000 nM with a dilution factor of 5. Assay for each peptide is performed with three replicates. The last row H has no competing target peptide.
Row H, columns 1-6 contain only MHCII and labeled probe peptide, no competing target peptide, allowing for measurement of FP for labeled probe peptide bound with MHCII without competitor peptide (FP_no_comp).
Row H, columns 7-12 contain only labeled probe peptide, no MHCII and competing target peptide, allowing for measurement of FP for free unbound labeled probe peptide (FP_free).